IC Biomedical is the first cryogenic equipment manufacturer to receive the new Enhanced MDR Certification

Last week, IC Biomedical became the first cryogenic storage equipment manufacturer to receive the new enhanced European MDR Certification. We learned this while exhibiting with our distribution partner, Linde Gas Benelux, at Laborama in Brussels. Linde Gas Benelux provides the highest- quality certified products and services to the European medical and biopharmaceutical research community. They displayed our newest Revolution freezer and promoted its innovative features and high levels of safety and compliance. Dr. Ulrich Kühn is shown presenting our new MDR certificate to Linde Gas Benelux’s Stephen Aerts. All IC Biomedical products are produced at our ISO 13485:2016-certified medical grade facility in Cartersville, Georgia.

New 10DX Vapor Shipper for Large Quantities of Biomaterials in Regulated Environments

The new IC Biomedical 10DX vapor shipper is designed for shipping biomaterials in larger quantities and can be validated to the longest hold time in the industry for a shipper of its size. With a 5-cryobox capacity or space for multiple bag cassettes, the 10DX is a very versatile vessel. Our uniquely designed shipping case (Model 10LSC) provides excellent protection for the 10DX during road or air shipments.

Many of the typical end-user applications for the 10DX are in regulated environments. Compliant data logging options during shipment are available, including simple temperature logging, full GPS tracking, tilt and ambient environment recording.

The 10DX uses a Hydrophobic Adsorbent material that can be easily decontaminated between shipments if required by the application.

For more information on our full line of vapor shippers, click here.

Ian Pope Teaching in BioCor’s “Preservation of Cellular Therapies” Short Course at the University of Minnesota

On May 23 – 24, 2023, The University of Minnesota is presenting a top-notch short course titled “Preservation of Cellular Therapies.” IC Biomedical’s Chief Commercial Officer, Ian Pope, a thought leader and acknowledged expert in cryogenic and ultra-cold storage and transport, is part of the distinguished teaching group for this 2-day course.

Currently 1.2 million patients are receiving treatment from regenerative medicine products produced by 171 companies with a capital value of ~$4.7 billion. Most molecules, cells and tissues are collected at a given time and location for use at a later time. Therefore, our ability to stabilize biological properties (e.g. viability, biomarkers) during transportation and long-term storage is a critical technology.

The preservation of cellular therapies is the central focus of this professional short course. Learn about the fundamentals of preservation, protocol development, design of a storage facility, regulatory issues associated with preservation of cell therapies, clinical issues and more.

Click here for more information and to register.

ISO 13485:2016 Certification Achieved

MARCH 2022 – One of the first strategic goals for IC Biomedical was to build a world class biomedical cold storage business and to manufacture our products in a medical device compliant facility.  The key step to achieving global medical device compliance was the development and certification of an ISO 13485:2016 Quality Management System (QMS).   An ISO 13485:2016 QMS is designed to be used by organizations involved in the design, production, installation and servicing of medical devices and related services.  Additionally, the required processes ensure medical devices and related services consistently meet customer and applicable global regulatory requirements.

IC Biomedical is proud to announce ISO 13485:2016 certification was achieved in March 2022, less than a year after the Cartersville GA manufacturing facility was opened.  This certification is a key step in obtaining global medical device approvals and registrations for all IC Biomedical products.     

New Upright Shipping Case Design for Vapor Shippers

An IC Biomedical CX100 Vapor Shipper will maintain cryogenic temperatures for up to 20 days if kept in an upright position. Unfortunately, if the shipper is oriented sideways during transit and handling it can cut this time by up to 50%. With shipping times getting longer and package handling getting rougher, IC Biomedical has designed a new Case that provides a safer, more secure enclosure for nitrogen vapor shippers.

The new IC BIomedical Shipping Case is made of high-impact-resistant material to protect its contents from physical damage. The Case’s domed top prevents stacking and its circular wide base encourages upright orientation during handling and transit.

Designed for IC Biomedical shippers 4D, 4DX, CX100 and CXR100, the Shipping Case is also compatible with most other similar-sized shippers available on the market. A built-in slot allows the case to be locked down for added sample security.

Height: 24-inches
Base Diameter: 15-inches
Weight: 14

IC Biomedical Builds Medical-Grade Manufacturing Facility in Cartersville, Georgia

IC Biomedical, a producer of cryogenic freezers, will make a multi-million dollar investment in opening an advanced manufacturing facility near Cartersville, Georgia. The project is expected to create more than 80 jobs in Bartow County.

The company will operate in a recently constructed 75,000-square-foot facility located on Cass-White Road. According to state officials, the demand for medical-grade freezers continues to surge.

“IC Biomedical is committed to manufacturing class-leading products with innovation, quality, and technical excellence,” said CEO of IC Biomedical Steve Shaw. “Georgia was the obvious choice for us, a highly trained workforce, transport links, and a state infrastructure committed to the life science sector that is able to support our business in a way no other location could offer.”

“Recent events have proven the importance of IC Biomedical’s products within our global health ecosystems,” said GDEcD Commissioner Pat Wilson. “Home to top-ranked research universities and organizations including the Centers for Disease Control and Prevention and the Task Force for Global Health, Georgia is a hotbed for every aspect of the life sciences industry, from research and development to production and distribution. I’m confident IC Biomedical will find great success here, and I thank Steve Shaw for reinvesting in his hometown.”

IC Biomedical manufactures premium cryogenic equipment, including stainless steel and aluminum freezers, Dewars, shippers, and other custom equipment used for safe storage and transportation of medical products such as vaccines, therapies, and other biological specimens.

“Congratulations to IC Biomedical on the selection of Cartersville for their new manufacturing facility,” said Katie Kirkpatrick, president and CEO of the Metro Atlanta Chamber. “We are pleased to have IC Biomedical join metro Atlanta’s growing life sciences community with assets like Emory School of Medicine, Morehouse School of Medicine, Centers for Disease Control and Prevention, Georgia Tech and the many businesses engaged in research, development, manufacturing, and distribution of life science related products and supplies.”

Milton Street Capital Forms IC Biomedical, Simultaneously Acquires The Life Sciences Business of Worthington Industries and International Cryogenics, Inc.

October 30, 2020

Milton Street Capital, a Houston-based lower middle market private equity firm, today announced the simultaneous acquisition of the Life Sciences business of Worthington Industries and International Cryogenics, Inc. Following the closing, these two cryogenic biomedical equipment manufacturers will operate under IC Biomedical (  

The Life Sciences business of Worthington Industries (“Life Sciences”), located in Theodore, AL, is a market leading manufacturer of cryogenic stainless steel and aluminum storage freezers, dewars and shippers used to store biological specimens. The Life Sciences business was previously owned by Taylor-Wharton, which sold its biomedical storage products under the “CryoScience by Taylor-Wharton” brand.  The business has a 50-year legacy of supplying high quality products to the demanding global biomedical research and development, healthcare, biorepository, pharmaceutical, biotechnology, IVF and animal breeding markets.    

International Cryogenics, Inc. (“ICI”), based in Indianapolis, IN, is a manufacturer of cryogenic aluminum, freezers, dewars, shippers and custom products for biomedical applications. With a long history dating back over 40 years, ICI is a well-known as a high quality manufacturer in the industry.

IC Biomedical will be led by Steve Shaw, CEO and Jim Hoppel, CFO.   Steve has over 25 years of cryogenic biomedical market experience that includes President of  of Chart Industries’ former BioMedical Group (MVE and Caire). Jim was formally the CAO and VP, Corporate Development at Chart Industries and CFO at Taylor-Wharton.

“We are thrilled to partner with Steve and Jim to form IC Biomedical. The combination of Steve’s leadership experience and well-known market presence, and Life Sciences’ and ICI’s long history of manufacturing high quality cryogenic biomedical storage products makes this an excellent fit,” said Francis Carr, a Managing Partner at Milton Street. “Biomedical cold storage is a high growth sector, and we are excited to partner with an industry-leading management team to build a company that is both customer focused and operationally excellent.” 

“Milton Street’s experience in complex corporate carve-out transactions made them the ideal partner for combining Worthington’s Life Sciences business and ICI,” said Steve Shaw, CEO of IC Biomedical. “We look forward to executing on our vision to build a leading biomedical cold storage business. The merger of these two established businesses provides an unequalled platform to serve an ever growing and more demanding biomedical market. We will manufacture in a medical device accredited facility providing products with the highest regulatory compliance and quality. The distribution partners and customers of IC Biomedical can be assured that we will provide an increased level of support and partnership moving forward with a program of new product development and a significant investment in quality.”

About Milton Street Capital

Milton Street Capital is a Houston-based private equity firm that targets control investments in North American-based, lower middle-market industrial manufacturing, distribution and services companies. Milton Street has a bias towards overlooked and underinvested companies where there is a significant opportunity to drive value creation through commercial and operational improvements. This will be the third platform investment from Milton Street Capital Fund I.  For further information, please visit